Ifp Advisors, Inc Amphastar Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 2,035 shares of AMPH stock, worth $51,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,035

Previous 1,158 75.73%

Holding current value

$51,404

Previous $33,000 39.39%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$22.96 - $28.29 $20,135 - $24,810	877 Added 75.73%	2,035 $46,000
Q1 2025 May 05, 2025	BUY	$26.24 - $38.48 $30,385 - $44,559	1,158 New	1,158 $33,000
Q4 2024 Feb 04, 2025	BUY	$36.84 - $53.4 $0 - $0	0 New	0 $0
Q4 2022 Feb 07, 2023	SELL	$27.93 - $31.27 $2,094 - $2,345	-75 Reduced 80.65%	18 $3,000
Q3 2022 Nov 08, 2022	SELL	$27.56 - $37.75 $2,370 - $3,246	-86 Reduced 48.04%	93 $6,000
Q2 2022 Sep 06, 2022	BUY	$29.79 - $42.29 $5,332 - $7,569	179 New	179 $7,000
Q2 2022 Aug 12, 2022	SELL	$29.79 - $42.29 $5,332 - $7,569	-179 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$22.96 - $36.45 $4,109 - $6,524	179 New	179 $6,000
Q1 2019 May 15, 2019	SELL	$19.46 - $25.28 $27,438 - $35,644	-1,410 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$15.39 - $19.38 $1,539 - $1,938	100 Added 7.63%	1,410 $0
Q2 2018 Aug 07, 2018	BUY	$14.63 - $19.6 $14,630 - $19,600	1,000 Added 322.58%	1,310 $0
Q1 2018 Jun 03, 2019	SELL	$17.23 - $20.35 $17,230 - $20,350	-1,000 Reduced 76.34%	310 $6,000
Q1 2018 May 09, 2018	BUY	$17.23 - $20.35 $17,230 - $20,350	1,000 Added 322.58%	1,310 $0
Q4 2017 Jan 24, 2018	SELL	$17.76 - $19.75 $22,200 - $24,687	-1,250 Reduced 80.13%	310 $0
Q3 2017 Oct 30, 2017	BUY	$14.73 - $17.99 $22,978 - $28,064	1,560	1,560 $28,000

Others Institutions Holding AMPH

# of Institutions

261

Shares Held

32.9M

Call Options Held

18.3K

Put Options Held

13K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.24B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account